---
$id: https://graph.org.ai/products/commodity/51171922
$type: Product
source: UNSPSC
code: "51171922"
title: "Tegaserod"
class: "51171900"
classTitle: "Antiulcer and related gastrointestinal GI drugs"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tegaserod

**UNSPSC Code**: 51171922
**Class**: [Antiulcer and related gastrointestinal GI drugs](Antiulcer and related gastrointestinal GI drugs.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a serotonin antagonist with the molecular formula C16H23N5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 458VC51857, chemically known as hydrazinecarboximidamide, 2-((5-methoxy-1h-indol-3-yl)methylene)-n-pentyl- but generally known as tegaserod, which bears US NIH Compound Identifier 5487301. European Medicines Agency schedules Tegaserod in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04713MIG. The term TEGASEROD is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 1, 1999, List 41). World Health Organization schedules tegaserod in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule tegaserod under HS 29339990 and SITC 51577. As of Q4 2014, TEGASEROD remains the US FDA Preferred Term for this commodity. Tegaserod bears US NLM identifiers UMLS ID C0537147 and NCI Concept Code C66583. SMILES: OCC1CC2C(N=CC\2=C/NN/C(=N/CCCCC)N)CC1.

